Vanguard Group »

Blueprint Medicines shares owned by Vanguard Group

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Vanguard Group

Quarter filed Position value Share count Share price at filing
2024-06-30 $705M 6.5M 107.78
2024-03-31 $599M 6.3M 94.86
2023-12-31 $564M 6.1M 92.24
2023-09-30 $300M 6.0M 50.22
2023-06-30 $375M 5.9M 63.20
2023-03-31 $265M 5.9M 44.99
2022-12-31 $253M 5.8M 43.81
2022-06-30 $284M 5.6M 50.51
2022-03-31 $353M 5.5M 63.88
2021-09-30 $574M 5.6M 102.81
2021-06-30 $490M 5.6M 87.96
2021-03-31 $536M 5.5M 97.23
2020-12-31 $582M 5.2M 112.15
2020-09-30 $445M 4.8M 92.70
2020-06-30 $385M 4.9M 78.00
2020-03-31 $285M 4.9M 58.48
2019-12-31 $350M 4.4M 80.11
2019-09-30 $319M 4.3M 73.48
2019-03-31 $317M 4.0M 80.04
2018-12-31 $206M 3.8M 53.87
2018-09-30 $292M 3.7M 78.06
2018-06-30 $230M 3.6M 63.48
2018-03-31 $310M 3.4M 91.70
2017-12-31 $250M 3.3M 75.41
2017-09-30 $135M 1.9M 69.81
2017-06-30 $72M 1.4M 50.66
2017-03-31 $49M 1.2M 39.99
2016-12-31 $26M 907k 28.57
2016-09-30 $21M 713k 29.69
2016-06-30 $12M 567k 20.25
2015-12-31 $13M 505k 26.33
2015-09-30 $4.6M 216k 21.31
2015-06-30 $4.9M 185k 26.51